All the news

#GRANTWINNERS: identified new mechanism involved in thrombus formation in LVAD device

23 July 2019
Attività di ricerca

Thanks to a funding from Fondazione Cariplo for young researchers, it was possible to study the mechanisms underlying thrombus formation in patients undergoing LVAD implantation. The project manager is Filippo Consolo, Biomedical Engineer and Researcher at the Faculty of Medicine and Surgery UniSR.

Their study focused on thromboembolic complications in LVAD patients, i.e. those complications that develop due to thrombus formation (accumulation of platelets, red blood cells and/or white blood cells) inside the pump. The thrombi hamper or prevent the normal operation of the device; these events are characterized by a high mortality rate.

Filippo Consolo states:

By analyzing the data in the literature we have observed that thromboembolic complications in LVAD patients often occur as a consequence of intraventricular thrombus formation, i.e. the thrombus is originally formed inside the ventricle and from there it moves inside the pump. The fact that in these patients the thrombus generates precisely in the anatomical implantation site of the device has led us to suppose the presence of peculiar mechanisms (not entirely known) in that district, that favor the onset of the pathology”.

The funded project set out to analyze the cellular mechanisms of interaction between platelets and the endothelium (internal cell lining) of the ventricle. The multidisciplinary team identified a possible “triggering” mechanism of intraventricular thrombosis, due to a combined effect of LVAD-mediated platelet activation and cytokine-mediated inflammatory endothelium activation.

To date, the antithrombotic therapy used in LVAD patients does not contemplate these phenomena and it is not able to prevent them. Achieving this goal could lead to a significant reduction in the rate of thrombo-embolic complications – often deadly or otherwise highly disabling. Reducing complications is therefore essential in order to increase patients’ life expectancy”.

Read the full news on our blog UniScienza&Ricerca

Share news

You might be interested in

Plenary Lecture: “The physiopathologic interplay between muscle and nerve in ALS”
Attività di ricerca03 December 2019
Plenary Lecture: “The physiopathologic interplay between muscle and nerve in ALS”
Plenary Lecture:
Attività di ricerca15 November 2019
Plenary Lecture: "Role of unusual RNA/DNA structures in health and disease"
Eleonora Dondossola, a former UniSR biotechnologist, is in the Nature Research Award for Inspiring Science shortlist
Attività di ricerca04 October 2019
Eleonora Dondossola, a former UniSR biotechnologist, is in the Nature Research Award for Inspiring Science shortlist
Dr. Conte wins the
Attività di ricerca24 September 2019
Dr. Conte wins the "Future Leaders Mentorship Program for Clinical Diabetologists" Award